Companies: 10,795·Total market cap: $144.5T
Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company

4016.SRSAUHealthcare● Active
$62.10
$-0.20(-0.32%)
Market Cap$2.2B
P/E Ratio
52W High$79.08572
52W Low$53.88572
Overview

Middle East Pharmaceutical Industries Company(4016.SR)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · 4016.SR · 截至 2026-06-16

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$0.10B$0.08B$0.07B$0.06B$0.07B
Depreciation & Amort.$0.02B$0.02B$0.01B$0.01B$0.01B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.03B)($0.07B)$0.02B($0.01B)($0.04B)
Net Cash from Operations$0.09B$0.04B$0.09B$0.06B$0.04B
Investing Activities
Capital Expenditure($0.01B)($0.01B)($0.02B)($0.02B)($0.02B)
Purchases of Investments$0.00B$0.00B$0.00B$0.00B($0.00B)
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.03B)($0.02B)($0.03B)($0.02B)($0.02B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B$0.00B
Dividends Paid($0.05B)($0.01B)($0.04B)($0.04B)($0.04B)
Debt Issued / Repaid$0.00B($0.01B)($0.01B)($0.00B)$0.02B
Net Cash from Financing($0.05B)($0.01B)($0.07B)($0.04B)($0.01B)
Free Cash Flow
Free Cash Flow$0.08B$0.02B$0.07B$0.04B$0.02B
FCF Margin %(computed)17.01%6.12%21.22%14.55%5.58%

数据来源:Financial Modeling Prep · 最后更新:2026-06-16 · SAR · B

深入了解Middle East Pharmaceutical Industries Company

关于Middle East Pharmaceutical Industries Company(4016.SR)现金流量表

Middle East Pharmaceutical Industries Company 2025财年经营活动现金流$0.09B,自由现金流$0.08B(FCF利润率17.01%),资本支出($0.01B)。

常见问题

4016.SR · 4 问

Middle East Pharmaceutical Industries Company 2025财年自由现金流$0.08B,同比up224.6%。

4016.SR free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-16